Document:

Exhibit 4.19

 Exhibit 4.19 

AMENDED AND RESTATED EMPLOYMENT AGREEMENT

THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT dated for reference January 1, 2005.

BETWEEN:

FORBES MEDI-TECH INC., a company having an office at #200 - 750 West Pender Street, Vancouver, B.C. V6C 2T8

(the "Company")

AND:

DAVID STEWART, an individual residing at #103-3625 Windcrest Drive, 

N. Vancouver, BC, V7G 2S6

(the "Employee")

WHEREAS:

A.

The Company has employed the Employee as Vice President, Regulatory Affairs (Nutraceutical) and Scientific Services;

B.

The parties wish to modify certain terms of the employment agreement between the Employee and the Company and to re-state such employment agreement on the terms and conditions hereof; 

THEREFORE in consideration of the recitals, the following covenants and the payment of one dollar made by each party to the other, the receipt and sufficiency of which are acknowledged by each party, the parties agree on the following terms:

1.

EMPLOYMENT

1.1

The Company hereby confirms the employment of the Employee in the position of Vice President, Regulatory Affairs (Nutraceutical) and Scientific Services (the "Position"), and the Employee accepts such employment and agrees to carry out the duties and responsibilities specified herein or otherwise required for the Position to the best of his or her abilities and in accordance with the terms and conditions of this Agreement.

2.

DUTIES AND RESPONSIBILITIES

2.1

Initial Duties  The Employee shall, pursuant to this Agreement, perform all duties customarily performed by a Vice President, Regulatory Affairs (Nutraceutical) and Scientific Services, in a business similar to the Company's business. 

2.2

Position may evolve or vary  The Employee understands and agrees that the above noted duties and responsibilities, and the Employee's Position, may evolve or vary from time to time over the course of the Employee's employment to deal with changing business conditions, corporate expansion or reorganization, and/or an evolving regulatory environment, and consents to such reasonable variations in such duties and responsibilities, and in the Position, as may reasonably be required by the Company from time to time as a result.  The Company shall not be deemed to have waived the right to require the Employee to perform any duties hereunder by assigning the Employee to any other duties or services or by assigning another individual to perform the duties of the Employee.

2 of 9

2.3

Best Efforts  The Employee shall use his or her best efforts to promote the interests of the Company and will perform faithfully, honestly and efficiently and in the best interest of the Company in carrying out such responsibilities.

2.4

Full-Time Position  The Position is a full-time position, and accordingly the Employee shall devote his or her full business time to the business and affairs of the Company.

2.5

Reporting  The Employee shall report directly to the Chief Scientific Officer, (the President & CEO in their absence) and / or such other persons(s) as the Board of Directors shall direct from time to time.

2.6

Rules and Regulations  The Employee will, subject to the terms of this Agreement, comply promptly and faithfully with the Company's reasonable instructions, directions, requests, rules, policies and regulations, and the Employee acknowledges and agrees that the Company may, acting reasonably, modify such rules, policies and regulations from time to time to deal with new or changing circumstances.

3.

REMUNERATION AND BENEFITS

3.1

Annual Base Salary  Commencing January 1, 2005 the Employee shall be paid an annual base salary of $120,000.00 per annum (the "Annual Base Salary"), exclusive of bonuses, benefits and other compensation, payable in equal bi-monthly instalments in arrears, on the fifteenth day and last days of each month.  Should the fifteenth or last day of any month not be a business day, the Employee's salary otherwise due on such date shall be paid to the Employee on the immediately preceding business day.

3.2

Annual Base Salary Increases  The Annual Base Salary of the Employee will be reviewed on an annual basis and, subject to factors such as the financial and operational performance of the Company and the performance of the Employee in carrying out his or her responsibilities hereunder, such Annual Base Salary may be increased.  Should the Company increase the Employee's Annual Base Salary, then the Company may, at its option, require the Employee to execute a new form of Employment Agreement with the Company to reflect such increase.  Additionally, and in further consideration of any increase in the Employee's Annual Base Salary or other compensation, the Company reserves the right to make other modifications and alterations to this Employment Agreement including, but without limitation, alterations to provisions relating to confidentiality, trade secrets, inventions and non-competition.

3.3

Vacation and Other Holidays  The Employee shall be entitled to three weeks' paid vacation each year.  After 3 years of full employment, the Employee shall be entitled to four weeks' paid vacation each year.  The Employee may not carry over any unused vacation from year to year without the prior written consent of the Company.  In addition, the Employee shall be entitled to the number of paid holidays provided for under the current policies and procedures of the Company.

3 of 9

3.4

Additional Employee Benefits  In addition to any other compensation or benefits to be received by the Employee pursuant to this Agreement, the Employee shall be entitled to participate in all employee health, medical, pension or other related benefits which the Company shall from time to time provide to its employees.

3.5

Name and Likeness  The Employee hereby grants to the Company the right to use the Employee's name, likeness and / or biography in connection with the services performed by the Employee under this Agreement and in connection with the advertising or exploitation of any project or product with respect to which the Employee is involved, or otherwise in connection with the business of the Company.

4.

CONFIDENTIALITY AND INVENTIONS

4.1

Confidentiality and Inventions Agreement ("CIA")  The parties have entered into a Confidentiality and Inventions Agreement dated December 8, 1997 (the "CIA").  The Employee acknowledges and agrees that his or her obligations under the CIA are fundamental terms of his or her employment with the Company.  Any breach of the CIA by either party shall be deemed to be a breach of this Agreement by such party.

4.2

Modification of CIA  The parties may amend, modify, alter, supplement or replace the CIA from time to time, and acknowledge and agree that the provisions of this Agreement which reference the CIA shall mean and refer to the CIA as so amended, modified, altered, supplemented or replaced.

5.

TERMINATION

5.1

Notice and Severance Period   For purposes of this Section 5:

(a)

“Notice” means notice given by the Company to the Employee terminating the Employee’s employment with the Company; and 

(b)

“Severance Period” means that number of months following the date that Notice is given which is set out below:

If Notice is Given:

Then the Severance Period will be:

Prior to June 1, 2005

12 months 

On or after June 1, 2005 and 

prior to June 1, 2006

14 months

On or after June 1, 2006 and 

prior to June 1, 2007

16 months

On or after June 1, 2007

18 months. 

4 of 9

5.2

Termination on Notice or With Pay in Lieu of Notice  The Company may terminate the Employee in the following circumstances, at the option of the Company:

(a)

on reasonable notice, which the parties agree shall equal the Severance Period applicable to the date that Notice is given set out in section 5.1 above, in which case the Employee will be obligated to continue performing his or her duties and responsibilities during such Severance Period pursuant to the terms of this Agreement; or

(b)

on the giving of Notice and payment of an amount of severance in lieu of reasonable notice, which the parties agree shall equal the amount of Annual Base Salary otherwise payable during the Severance Period applicable to such Notice as set out in section 5.1, in which case the Employee will cease his or her employment with the Company upon termination; or

(c)

on giving less notice than is required pursuant to sub-section (a), provided that at the end of the Notice period actually given, the Employee is paid an amount of severance equal to the amount of Annual Base Salary the Employee would have been paid had the Employee worked for a period of time (the "Remaining Notice Period") equal to the Severance Period applicable to the Notice given, as set forth in section 5.1, less the notice period actually given, in which case the Employee will be obligated to continue performing his or her duties and responsibilities only during the notice period actually given.

5.3

Period of Notice, or Combination of Notice plus Severance, not to exceed 18 months  If the Company elects to terminate the Employee on notice pursuant to Section 5.2(a) herein, or by combination of notice plus severance pursuant to section 5.2(c) herein, then the Company shall not be obligated to provide notice of termination, or any combination of notice of termination plus severance for the Remaining Notice Period, exceeding 18 months.

5.4

Payment of Severance not to exceed 18 months.  If the Company elects to terminate the Employee by a payment of severance in lieu of notice pursuant to Section 5.2(b) herein, or by combination of notice and severance pursuant to Section 5.2(c) herein, then the Company reserves the right to pay the amount of such severance on the dates the Employee would otherwise have received his or her Annual Base Salary had the Employee's employment not been terminated, provided however, that the Company shall not be obligated to provide severance beyond

(a)

that date which is 18 months from the date of Notice; or

(b)

the Remaining Notice Period, in the case of a combination of notice and severance pursuant to section 5.2(c) herein; or 

(c)

that date upon which the Employee commences employment or secures a full time consulting or analogous contract with another entity.  The Employee, acting in good faith, shall be obligated to notify the Company as to the date upon which he or she is commencing employment or providing full time consulting services;

whichever shall first occur.

5 of 9

5.5

Termination for Cause  The Company may also terminate the Employee's employment under this Agreement at any time upon the occurrence of any of the following events which are deemed by the Company to be just cause , in which case the Company shall pay to the Employee no more than the full amount of compensation accrued pursuant to section 3.1 of this Agreement up to the date of such termination:

(a)

the Employee acting unlawfully, dishonestly, negligently, incompetently or otherwise acting in bad faith;

(b)

the conviction of the Employee of a criminal offence;

(c)

an event of a substance abuse by the Employee, or an event of sexual harassment or similar reprehensible conduct, which the Company, acting reasonably and responsibly, determines to be incompatible with the Employee's continued employment by the Company;

(d)

the Employee becoming permanently disabled or disabled for a period exceeding 180 consecutive days or 180 days calculated on a cumulative basis over any two year period during the term of this Agreement; or

(e)

the breach or default of any term of this Agreement or the CIA by the Employee if such breach or default has not been remedied to the satisfaction of the Company within 14 days after written notice of the breach or default has been delivered by the Company to the Employee.

5.6

Termination by Employee   The Employee may terminate his or her obligations under this Agreement:

(a)

on 30 days notice in writing, to the Chief Scientific Officer, (the President & CEO in their absence) or other person to whom the Employee normally reports; or

(b)

upon the breach or default of any term of this Agreement or the CIA by the Company if such breach or default has not been remedied to the satisfaction of the Employee within 14 days after written notice of breach or default has been delivered by the Employee to the Company.

5.7

Payment on Termination by Employee   In the event of the termination of the Employee's employment under section 5.6 of this Agreement, the Company shall pay, within 10 days of the effective date of termination, the full amount of compensation accrued pursuant to section 3.1 of this Agreement as of the date of termination.   

5.8

Additional Payment on Termination by Employee Following a Change of Control   In the event that the Employee terminates his or her obligations under section 5.6 within 6 months following a Change of Control (as defined below), then, in addition to the payment required under section 5.7, the Company shall, within 10 days of the effective date of termination of the Employee’s employment hereunder, pay to the Employee an amount equal to the amount of Annual Base Salary otherwise payable during the Severance Period applicable under section 5.1 of this Agreement had the date the Employee gave notice of termination to the Company been the date of Notice for purposes of determining the Severance Period.  A “Change of Control” shall be deemed to have occurred when:

6 of 9

(a)

a person other than the current control person of the Company (as that term is defined in the Securities Act (British Columbia), if any, becomes a control person; or

(b)

a majority of the directors elected at any annual or special general meeting of shareholders of the Company are not individuals nominated by the Company's then-incumbent Board.  

5.9

Rights in Law and Equity  No remedy herein conferred upon any party is intended to be exclusive of any other remedy available to that party but each remedy shall be cumulative and shall be in addition to every other remedy given hereunder or now or hereafter existing by law or in equity or by statute.

5.10

Delivery of Company Property  Upon the termination of the Employee's employment with the Company for any reason, the Employee will deliver to the Company all property of the Company in the possession or control of the Employee, including but without limitation, all Confidential Information (as defined in the CIA), security passes, keys and other property belonging to the Company or developed in connection with the business of the Company.

6. 

NON-COMPETITION

6.1

Consideration  The Employee acknowledges and agrees that his or her increased compensation under this Employment Agreement is in consideration of his or her agreement with the restrictive terms of this Section 6 and of the CIA.

6.2

Non-Competition During Employment  During the period the Employee is employed by the Company, the Employee shall not, individually or in partnership or jointly or in conjunction with any person as principal, agent, employee, contractor, landlord, consultant, supplier, lender, financier, shareholder, or in any other manner, directly or indirectly, engage in, carry on or provide services to or otherwise be concerned with any other business in any of the fields of biotechnology, pharmaceuticals, functional foods or nutraceuticals (a "Competitor") provided that this restriction shall not apply to the Employee's ownership of less than 10% of the publicly traded securities of a Competitor.

6.3

Post-Employment Non-Competition Covenants  The Employee covenants and agrees with the Company that, for a period of 12 months from the date the Employee ceases his or her employment with the Company, the Employee shall not individually or in partnership or jointly or in conjunction with any person as principal, agent, employee, contractor, consultant, landlord, supplier, lender, financier, shareholder, or in any manner whatsoever:

(a)

within the Territory, directly or indirectly engage in, carry on, provide services to or otherwise be concerned with or have any interest in, advice, lend, advise, lend money to, guarantee the debts or obligations of or otherwise provide financial assistance to, act as an agent of or permit his or her name or any part thereof to be used or employed in connection with any Competitive Entity, as defined in Section 6.4 below;

7 of 9

(b)

solicit, offer to employ or engage or accept as an employee any person who is employed or engaged by the Company or any of its affiliates or who was so employed or engaged during any part of the 12 months immediately preceding the date of the Employee's termination;

(c)

advise any person or entity not to do business with the Company or any of its affiliates or otherwise take any action which may reasonably result in the relations between the Company or any of its affiliates and any of its employees or customers or potential employees or customers being impaired; or

(d)

assist any person or entity to do any things set out in clauses (a) through (c) above.

6.4

Competitive Entity  "Competitive Entity" shall mean any business in any of the fields of biotechnology, pharmaceuticals, functional foods or nutraceuticals, where such business conducts, has conducted or intends to conduct research respecting, or has commercialized or intends to commercialize, any product, formulation or compound, which in any way directly conflicts or competes with the business or research and development of the Company.

6.5

Territory  "Territory" shall mean anywhere in the world.

6.6

Unilateral Curtailment of Restrictive Conditions  On notice by the Company to the Employee, the Company may unilaterally reduce the time period or geographic area(s) prescribed in any provision contained in this Section 6, or may restrict the definition of "Competitive Entity" to narrow its scope.

7.

MISCELLANEOUS

7.1

Waiver  No consent or waiver, express or implied, by either party to or of any breach or default by the other party in the performance by the other party of its obligations hereunder shall be deemed or construed to be a consent or waiver to or of any other breach or default in the performance of obligations hereunder by such party.  Failure on the part of either party to complain of any act or failure to act of the other party or to declare the other party in default, irrespective of how long such failure continues, shall not constitute a waiver by such party of its rights hereunder.

7.2

Giving Notice  Any notice relating to the Agreement or required or permitted to be given in accordance with this Agreement shall be in writing and shall be personally delivered or delivered by courier to the address of the parties set out on the first page of this Agreement.  Any notice shall be deemed to have been received when delivered.  Each party to this Agreement may change its address for the purpose of this Section by giving written notice of such change in the manner provided for in this Section.

8 of 9

7.3

Governing Law  This Agreement shall be governed by and construed in accordance with the laws of the province of British Columbia and the federal law of Canada applicable therein, which shall be deemed to be the proper law hereof.  The parties hereto hereby submit to the jurisdiction of the courts of British Columbia.

7.4

Severability  Any provision of this Agreement which is determined to be void, unenforceable or invalid shall be severable from all other provisions thereof and hereof and shall not be deemed to affect or impair the enforceability of any such other provisions or this Agreement.

7.5

Entire Agreement  This Agreement constitutes the entire agreement between the parties hereto and there are no representations or warranties, express or implied, statutory or otherwise other than set forth in this Agreement and there are no agreements collateral hereto other than as are expressly set forth or referred to herein.  This Agreement supersedes and replaces all previous employment agreements between the parties and amendments thereto.  This Agreement cannot be amended or supplemented except by a written agreement executed by all parties hereto.

7.6

Enurement  All of the provisions of this Agreement shall be binding upon the Employee and shall be enforceable by the Company, its successors, affiliates and assigns.  This Agreement may be assigned by the Company without the consent of the Employee. This Agreement is personal to the Employee based upon the singular skill, qualifications and experience of the Employee and is not assignable by him or her.

7.7

Interpretation  Any reference to gender includes all genders, and the singular includes the plural and the body corporate.  No provision of this Agreement shall be construed against any party by virtue of that party having drafted and prepared this Agreement; it being acknowledged and agreed that both parties participated in the negotiation, drafting and preparation of this Agreement.  All headings are inserted for reference only.  References in this Agreement to "this Agreement" means and include any Schedules hereto.

7.8

"Company" includes subsidiaries and affiliates  The term "Company" includes any affiliates, including without limitation, subsidiaries, of the Company.

7.9

Legal and Financial Advice  The Employee hereby represents, warrants and acknowledges to the Company that he or she has had the opportunity to seek and was not prevented nor discouraged by the Company from seeking independent legal and financial advice prior to the execution and delivery of this Agreement.

7.10

Counterparts  This Agreement may be executed in counterparts and such counterparts together shall constitute one and the same instrument.

7.11

Survival  The CIA and any provisions contained herein regarding non-competition following termination of employment shall survive the termination of this Agreement and the Employee's employment with the Company.

9 of 9

IN WITNESS WHEREOF the Parties have duly executed this Agreement as of the date set out on the first page of this Agreement.

FORBES MEDI-TECH INC.

Per:   

			
	      “Charles A. Butt”

	 
	      “David Stewart”

	 
	 
	 

	CHARLES A. BUTT

	 
	DAVID STEWART

	PRESIDENT & CEOExhibit 4.25

 Exhibit 4.25 

Execution Copy 

INVESTMENT AGREEMENT 

THIS AGREEMENT made this 19th day of March, 2008, 

AMONG: 

MATCO CAPITAL LTD., a body corporate 

  incorporated under the laws of the Province of Alberta 

("Matco") 

- and - 

FORBES MEDI-TECH INC., a corporation 

  incorporated under the laws of the Province of British 

  Columbia (the "Parent") 

- and - 

FORBES MEDI-TECH OPERATIONS INC., a 

  controlled subsidiary corporation of the Parent 

  incorporated under the Canada Business Corporations 

    Act (the "Subsidiary") 

     WHEREAS the Subsidiary has substantially completed a corporate reorganization and seeks to pursue a corporate business opportunity, with the assistance of Matco; 

     AND WHEREAS the Parent wishes to provide for the purchase from the Subsidiary by Matco of the Convertible Debenture, which has the terms that are herein provided. 

     NOW THEREFORE THIS AGREEMENT WITNESSES that, in consideration of this Agreement and the mutual terms and conditions set forth herein and other good and valuable consideration (the receipt and sufficiency of which is hereby acknowledged by each of the Parties), the Parties hereto agree as follows: 

ARTICLE 1 

INTERPRETATION 

	1.1 	Definitions 
	 	 
	 	 

     Capitalized terms used in this Agreement, including the recitals and Schedules attached to this Agreement, shall have the meanings specified for those terms below, and if no meaning is specified for a capitalized term below, then that term shall have the meaning provided for that term in the part of this Agreement in which that term is defined: 

	          (a)      	"Acquisition Rights" has the meaning ascribed to that term in Section 7.1(h); 
	 
	          (b)      	"Adjustment Factor" means the percentage determined by dividing the aggregate amount of Tax Attributes determined in accordance with Section 2.3 by -----------; 
	 

	
	Pricing information has been redacted in the provision marked above on the basis of confidentiality.

 

 

	          (c)      	"Agreement", "herein", "hereto", "hereof" and similar expressions refer to this agreement, including the recitals to this agreement, and not to any particular article, section, subsection or other subdivision of this agreement, and include every agreement varying, modifying, amending or supplementing this agreement; 
	 
	          (d)      	"Applicable Laws" means any statute, bylaw, rule or regulation or any judgment, order, writ, injunction or decree of any Governmental Entity to which a specified person or property is subject; 
	 
	          (e)      	"Audited Financial Statements" means the audited financial statements of the Subsidiary prepared by KPMG LLP for the three fiscal years ending December 31, 2007, December 31, 2006, and December 31, 2005; 
	 
	          (f)      	"Books and Records" means all books of account, tax records, sales and purchase records, business reports, plans and projections and all other documents, files, correspondence and other information of a Person (whether or not in written, printed, electronic or computer printout form); 
	 
	          (g)      	"Business Day" means any day other than a Saturday or a Sunday or a statutory holiday in Alberta; 
	 
	          (h)      	"Change of Control" in respect of a corporation means an acquisition of control in respect of such corporation within the meaning of the Tax Act; 
	 
	          (i)      	"Claims" means any claim, demand, lawsuit, proceeding, arbitration or governmental investigation; 
	 
	          (j)      	"Closing Date" means April 30, 2008, or such later date on or prior to the Outside Date as the Parties acting reasonably agree to in writing; 
	 
	          (k)      	"Convertible Debenture" means a secured debenture of the Subsidiary in the form attached hereto as Schedule C due April 30, 2009, which will bear interest at 8% compounded semi-annually and will be convertible at the holder’s option into 35% of the voting shares outstanding at Closing on a pro forma basis after giving effect to the issue of the Convertible Debenture, and all of the non-voting shares of the Subsidiary (representing, in the aggregate and on a fully diluted basis, 79% of all of the issued and outstanding shares of the Subsidiary outstanding at the Effective Time on a pro forma basis after giving effect to the issue of the Convertible Debenture); 
	 	 
	           (l)     	[Competitively sensitive information intentionally omitted.]
	 	 
	          (m)     	[Business sensitive information intentionally omitted.]
	 	 
	          (n)     	 "Deposit" has the meaning ascribed to that term in Section 2.1; 
	 	 
	          (o)     	 "Disclosure Schedule" means Schedule B; 
	 	 
	          (p)     	"Effective Time" means 9:00 a.m. on the Closing Date; 
	 	 

	Information regarding the manner in which the Parent and Matco will, after the Closing Date, source and pursue other opportunities to maximize the value of their respective interests in the Subsidiary and the proceeds to be received by the Parent as a result thereof has been redacted in the provision marked above on the basis of confidentiality.

- 2 - 

	          (q)      	"Encumbrances" means all liens, charges, pledges, mortgages, security interests, claims, and other encumbrances of whatsoever nature and kind, whether actual or contingent; 
	 
	          (r)      	"GAAP" means generally accepted accounting principles in effect in Canada including the accounting recommendations published in the Handbook of the Canadian Institute of Chartered Accountants; 
	 
	          (s)      	"Governmental Entity" means any applicable court or tribunal in any jurisdiction or any federal, provincial, municipal or other governmental body, agency, authority, department, commission, stock exchange, board, instrumentality, official or tribunal thereof; 
	 
	          (t)	[Competitively sensitive information intentionally omitted.]
	 
	         (u)	[Competitively sensitive information intentionally omitted.]
	 
	          (v)      	"Liabilities" means all indebtedness, liabilities and obligations of any kind whatsoever of the Subsidiary in respect of or relating to the assets, business, operations, contracts or commitments of the Subsidiary, whether actual or contingent, known or unknown, including any and all Losses; 
	 
	          (w)      	"Losses" means, in respect of any matter, any and all claims, demands, actions, proceedings, causes of action, losses, damages, liabilities, deficiencies, interest, penalties, fines, and amounts paid in settlement, costs and expenses of every nature and kind whatsoever (including, without limitation, all legal fees rendered on a solicitor and his own client basis and other professional fees and disbursements) arising directly or indirectly as a consequence of such matter, other than consequential, special and/or incidental damages or costs; 
	 
	          (x)      	"Matco Purchase" means the acquisition by Matco from the Subsidiary at the Effective Time of the Convertible Debenture pursuant to this Agreement; 
	 
	          (y)      	[Competitively sensitive information intentionally omitted.]
	 
	          (z)      	"Notice Documentation" has the meaning ascribed to that term in Section 5.7; 
	 
	          (aa)      	"Outside Date" means May 31, 2008, or such later date as the Parties acting reasonably agree to in writing; 
	 
	          (bb)	[Business sensitive information intentionally omitted.]
	 
	          (cc)      	"Parties" means the parties to this Agreement and "Party" means any one of them; 
	 
	          (dd) 	[Competitively sensitive information intentionally omitted.]
	 
	          (ee)      	"Person" means any individual, corporation, body corporate, partnership, joint venture, association, trust, Governmental Entity, or other legal entity; 
	 
	          (ff)      	"Purchase Price" has the meaning ascribed to that term in Section 2.2; 
	 

	Information regarding the manner in which the Parent and Matco will, after the Closing Date, source and pursue other opportunities to maximize the value of their respective interests in the Subsidiary and the proceeds to be received by the Parent as a result thereof has been redacted in the provision marked above on the basis of confidentiality.

 

- 3 - 

 
	        (gg)	[Business sensitive information intentionally omitted.]
	 
	         (hh)      	"Reorganization" means the reorganization of the Subsidiary referred to in Section 3.2 and described in detail in Schedule A; 
	 
	         (ii)      	"Representative" has the meaning ascribed to that term in Section 6.2; 
	 
	        (jj)	[Competitively sensitive information intentionally omitted.]
	 
	        (kk)	[Business sensitive information intentionally omitted.]
	 
	         (ll)      	"Subsidiary Shares" means all of the issued and outstanding common shares in the capital of the Subsidiary, which at the date hereof consists of, and at the Effective Time will consist of, 38,412,100 common shares; 
	 
	        (mm)      	 "Tax" or "Taxes" includes all taxes, surtaxes, duties, levies, imposts, rates, fees, assessments, withholdings, dues and other charges of any nature imposed by any Governmental Entity (including income, capital (including large corporations), withholding, consumption, sales, use, transfer, goods and services or other value-added, excise, customs, net worth, stamp, registration, franchise, payroll, employment, health, education, business, school, property, local improvement, development, education, development and occupation taxes, surtaxes, duties, levies, imposts, rates, fees, assessments, withholdings, dues and charges) together with all fines, interest, penalties on or in respect of, or in lieu of or for non- collection of, those taxes, surtaxes, duties, levies, imposts, rates, fees, assessments, withholdings, dues and other charges; 
	 
	         (nn)      	"Tax Act" means the Income Tax Act (Canada); 
	 
	         (oo)      	 "Tax Attributes" means the Subsidiary's Canadian federal and provincial scientific research and experimental development expenses, Canadian federal and provincial non- capital losses and Canadian federal investment tax credits; and 
	 
	 (pp)	[Competitively sensitive information intentionally omitted.]
	 

	Information regarding the manner in which the Parent and Matco will, after the Closing Date, source and pursue other opportunities to maximize the value of their respective interests in the Subsidiary and the proceeds to be received by the Parent as a result thereof has been redacted in the provision marked above on the basis of confidentiality.

 

- 4 - 

	1.2 	Sections and Headings 

     The division of this Agreement into Articles and Sections and the insertion of headings are for convenience of reference only and shall not affect the interpretation of this Agreement. Unless otherwise indicated, any reference in this Agreement to an Article, Section or Schedule refers to the specified Article or Section of, or Schedule to, this Agreement. 

	1.3 	Number, Gender 

     In this Agreement, words importing the singular number only shall include the plural and vice versa, words importing gender shall include all genders. 

	1.4 	Currency 

     Unless otherwise indicated, all dollar amounts in this Agreement are expressed in Canadian dollars. 

	1.5 	Accounting References 

     Where the character or amount of any asset or liability or item of income or expense is required to be determined, or any consolidation or other accounting computation is required to be made for the purposes of this Agreement, the same shall be done in accordance with GAAP except where the application of such principles is inconsistent with, or limited by, the terms of this Agreement. 

	1.6 	Statutory References 

      Except to the extent otherwise indicated, any reference in this Agreement to a statute includes all regulations made thereunder, all amendments to such statute or regulations in force from time to time and any statute or regulation that supplements or supersedes such statute or regulations.

	
	

	1.7 	Conflict or Inconsistency 

     Wherever any provision, whether express or implied, of any Schedule hereto conflicts or is at variance with any provision in the main body of this Agreement, the provision in the main body shall prevail. Wherever any provision, whether express or implied, of this Agreement conflicts with or is at variance with any documentation issued in furtherance hereof, the provision of this Agreement shall prevail. 

	1.8 	Best Efforts 

     When used herein, the term "best efforts" means that a Party shall use its commercially reasonable best efforts to secure the stated result. 

	1.9 	Schedules 

The following Schedules are attached to and form part of this Agreement: 

	 	Schedule A 	Summary of Transaction Steps 
		Schedule B 	Disclosure Schedule 
		Schedule C 	Form of Convertible Debenture 

 

- 5 - 

ARTICLE 2

DEPOSIT, PURCHASE AND SALE AND ADJUSTMENTS 

	2.1      	Deposit 
	 
	 	(a)      	Matco has provided to the Parent's legal counsel a cash deposit (the "Deposit") in the amount of --------. The Deposit has been and will be held in an interest-bearing trust account. Subject to Section 9.1, the Deposit and all interest earned thereon will be applied to the Purchase Price at the Effective Time. The Deposit and all interest earned thereon shall be returned to Matco and this Agreement shall terminate if the Effective Time does not occur on or before the Outside Date. 
	 
	 	(b)      	The Deposit shall be an indication of Matco's good faith and financial capability with respect to the transactions contemplated by this Agreement and shall be forfeit to the Parent as liquidated damages in the event each of the conditions precedent in Section 8.1 are satisfied or fulfilled and Matco does not complete the transactions contemplated by this Agreement by the Closing Date. 
	 

	2.2 	Purchase and Sale 

  

     Subject to the satisfaction of the conditions precedent set forth herein, Matco agrees to subscribe for and purchase the Convertible Debenture from the Subsidiary at the Effective Time. The consideration payable for the Convertible Debenture shall be cash in the amount of $3,000,000 ----------------------------------------- Guarantee (the "Purchase Price"), subject to adjustment in accordance with Section 2.3. 

	2.3 	Adjustments 

     Each of the Purchase Price ------------------------- is based on the assumption that immediately following the Effective Time the aggregate amount of the Tax Attributes will be ----------- after taking into account the intended income tax consequences of the Reorganization as agreed in writing by the Parent and Matco. If at or before the Effective Time it is determined that the aggregate amount of the Tax Attributes immediately following the Effective Time will be an amount other than ----------- and such difference results or will result from the application of the intended income tax consequences of the Reorganization or from any action taken or not taken by the Parent or the Subsidiary prior to the Effective Time or from any matter that occurred or arose prior to the Effective Time, then 

	 	 	(a)      	the cash portion of the Purchase Price shall be adjusted to the amount determined by multiplying $3,000,000 by the Adjustment Factor, and 
	 
	 	 	(b)	[Competitively sensitive information intentionally omitted.]
	 

ARTICLE 3

CORPORATE MATTERS RELATING TO PARENT AND SUBSIDIARY 

	3.1 	Reorganization of Subsidiary 

     Before or forthwith after execution of this Agreement, the Parent shall proceed expeditiously to complete the Reorganization substantially and materially in the manner described in Schedule A or in such other manner as the Parent may determine with the written consent of Matco acting reasonably. 

	Pricing information and information regarding the manner in which the Parent and Matco will, after the Closing Date, source and pursue other opportunities to maximize the value of their respective interests in the Subsidiary and the proceeds to be received by the Parent as a result thereof has been redacted in the provision marked above on the basis of confidentiality.

 

- 6 - 

	3.2      	Transfer of Assets and Liabilities 
	 
	 	The Parent will 
	 
	 	(a)      	cause the Subsidiary to transfer all of its assets, including an assignment to the Parent of the $3,000,000 proceeds payable by Matco under this Agreement from the sale of the Convertible Debenture but excluding the Tax Attributes, to the Parent, such transfer to be effective on or prior to the Closing Date; 
	 
	 	(b)      	assume all of the Liabilities of the Subsidiary, such assumption to be effective at, and for all times prior to, the Closing Date; 
	 
	 	(c)      	cause the Subsidiary to provide to each of the directors and officers of the Subsidiary an indemnity, in form and substance satisfactory to Matco acting reasonably, in respect of all Losses that may be suffered by such directors and officers that arise from or relate to their conduct as officers and/or directors of the Subsidiary; and 
	 
	 	(d)      	file, and cause the Subsidiary to file, all such tax elections as may be necessary or desirable in connection with such transfer and assumption. 

     Matco shall be satisfied, acting reasonably, with all such transfer and assumption documentation and tax elections to be filed in connection therewith prior to execution or filing thereof, and the Parent agrees to provide Matco with copies thereof for its prior written approval. The Parent shall also provide Matco with copies of all executed and filed documentation after execution and filing thereof and certified copies of all necessary corporate resolutions, consents or agreements regarding such transfer and assumption. 

	3.3 	Name Change 

     The Parent shall cause the name of the Subsidiary to be changed to a numbered corporation as part of the Reorganization, with effect on the Closing Date. 

	3.4 	Resignation of Officers and Directors 

     The Parent shall exercise its best efforts to ensure that a nominee of Matco is added to the board of directors of the Subsidiary and that such nominee, as well as Charles Butt and David Goold, shall be the sole officers and directors of the Subsidiary, effective as of the Effective Time. The Parent shall exercise its best efforts to cause such directors to continue as directors of the Subsidiary until the closing of a Corporate Opportunity, at which time it shall exercise its best efforts to cause each of Charles Butt and David Goold to resign as an officer and director and provide an unconditional mutual release of all claims he or she may have against the Subsidiary and vice versa, other than claims in respect of indemnification. 

 ARTICLE 4

[COMPETITIVELY SENSITIVE INFORMATION INTENTIONALLY OMITTED.]

ARTICLE 5

[COMPETITIVELY SENSITIVE INFORMATION INTENTIONALLY OMITTED.]

 ARTICLE 6 

  COVENANTS OF PARENT 

	6.1      	Covenants During Guarantee Period 
	 
	 	From the date hereof until the expiry of the Guarantee Period: 
	 
	 	(a)      	the Parent shall, and shall cause the Subsidiary to, observe, perform and comply in all material respects with all their respective covenants, agreements and obligations herein; 
	 
	 	(b)      	other than as contemplated by this Agreement ---------------------------------------------------------------------------------------------------------------------, the Parent shall not, and to the extent applicable shall cause the Subsidiary not to, without the prior written consent of Matco acting reasonably, 
	 
	 	 	 

(i)

issue any shares, options, warrants, calls, conversion privileges or rights of any kind to acquire any shares of the Subsidiary,

	Information regarding the manner in which the Parent and Matco will after the Closing Date source and pursue other opportunities to maximize the value of their respective interests in the Subsidiary and the proceeds to be received by the Parent as a result thereof has been redacted in the provision marked above on the basis of confidentiality.

 

- 7 - 

  
  

(ii)

sell, transfer, pledge, encumber or dispose of or agree to sell, transfer, pledge, encumber or dispose of any shares of, or any options, warrants, calls, conversion privileges or rights of any kind to acquire any shares of, the Subsidiary, including, after the Effective Time, the Remaining Shares,

(iii)

change or amend the constating documents or by-laws of the Subsidiary, or

(iv)

split, combine or reclassify any outstanding shares of the Subsidiary;

	          (c)      	other than as contemplated by this Agreement ---------------------------------------------------------------------------------------------------------------------, the Parent shall not, and to the extent applicable shall cause the Subsidiary not to, without the prior written consent of Matco acting reasonably, 
	 

	                    (i)      	redeem or purchase any shares of the Subsidiary, 
	 
	                    (ii)      	reorganize, amalgamate, merge or continue the Subsidiary with any other Person, 
	 
	                    (iii)      	take any action or make any commitment with respect to, or in contemplation of, any complete or partial liquidation, dissolution or other winding-up of the Subsidiary, 
	 
	                    (iv)      	declare and/or pay dividends or reduce the capital of the Subsidiary, 
	 
	                    (v)      	take any action -------------------------------------------------- that would or may give rise, in the opinion of Matco, acting reasonably, to a Change of Control of the Parent or the Subsidiary other than a Change of Control of the Parent in respect of which: 
	 

	                              (A)      	Matco has received written notice of the Parent not less than 90 days prior to the date of such Change of Control in accordance with Section 5.5(f) hereof; or 
	 
	                              (B)      	Matco has required the Parent to purchase the Convertible Debenture for an amount equal to the sum of the adjusted cash portion of the Purchase Price determined pursuant to Section 2.3(a) and ---------- pursuant to Section 5.5(f) and such purchase has been completed, 
	 

	                    (vi)      	take any action that would render, or that reasonably may be expected to render, any representation or warranty made by it in this Agreement untrue in any material respect at any time, 
	 
	                    (vii)      	enter into, assign, terminate or amend any contract or agreement in respect of the Subsidiary, 
	 

	Information regarding pricing the manner in which the Parent and Matco will after the Closing Date source and pursue other opportunities to maximize the value of their respective interests in the Subsidiary and the proceeds to be received by the Parent as a result thereof has been redacted in the provision marked above on the basis of confidentiality.

 

- 8 - 

  
  

	 	(viii)     	create any Encumbrance on any of the assets of the Subsidiary,
	 	 	 
	 	(ix)     	in respect of the Subsidiary, create, incur, guarantee, or assume any indebtedness for borrowed money or otherwise become liable or responsible for the obligations of any other Person,
	 	 	 
	 	(x)      	in respect of the Subsidiary, make any loans, advances, or capital contributions to, or investments in, any other Person, 
	 
	 	(xi)      	change in any respect any of the accounting principles or practices used by the Parent or the Subsidiary, except for any change required by reason of a concurrent change in GAAP; 
	 
	          (d)      	the Subsidiary shall not, and the Parent shall ensure that the Subsidiary does not, engage in any activity ---------------------------------------------------------; 
	 
	          (e)      	the Parent shall use its commercially reasonable efforts to cause its current insurance (or re-insurance) policies not to be cancelled or terminated or any of the coverage thereunder to lapse, except where such cancellation, termination or lapse would not individually or in the aggregate have a material adverse effect on the Parent, unless simultaneously with such termination, cancellation or lapse, replacement policies underwritten by insurance and re-insurance companies of nationally recognized standing providing coverage equal to or greater than the coverage under the cancelled, terminated or lapsed policies for substantially similar premiums are in full force and effect; 
	 
	          (f)      	the Parent shall use its commercially reasonable efforts to satisfy (or cause the satisfaction of) the conditions precedent to Matco's obligations hereunder to the extent that such matters are within its control and take, or cause to be taken, all other action and do, or cause to be done, all other things necessary, proper or advisable under all Applicable Laws to complete the transactions contemplated hereunder, including using its commercially reasonable efforts to: 
	 
	 	(i)      	obtain all necessary releases, waivers, consents and approvals required to be obtained by it or requested by Matco, acting reasonably, from other parties to leases and other contracts; 
	 
	 	(ii)      	obtain all necessary consents, approvals and authorizations that are required to be obtained by it under any Applicable Laws; and 
	 
	 	(iii)      	cooperate with Matco in connection with the performance by it of its obligations hereunder; 
	 
	          (g)      	the Parent shall make or cooperate as necessary in the making of all necessary filings and applications under all Applicable Laws required in connection with the transactions contemplated hereby and take all reasonable action necessary to be in compliance with such laws; 
	 
	          (h)      	the Parent will, within two Business Days of the Parent or the Subsidiary receiving any written audit inquiry, assessment, reassessment, confirmation or variation of an assessment, or indication that tax assessment is being considered, request for filing of a waiver or extension of time or any other notice in writing relating to Taxes attributable to a time period prior to the Effective Time, or Tax Attributes, deliver to Matco a copy thereof; and 
	 

	
	Information regarding pricing and the manner in which the Parent and Matco will after the Closing Date source and pursue other opportunities to maximize the value of their respective interests in the Subsidiary and the proceeds to be received by the Parent as a result thereof has been redacted in the provision marked above on the basis of confidentiality.

 

- 9 - 

	          (i)      	the Parent shall promptly notify Matco of any material adverse change, or any change which could reasonably be expected to become a material adverse change, in respect of its business or in the operation of its business, and of any material Governmental Entity or third party complaints, investigations or hearings (or communications indicating that the same may be contemplated) that would have a material adverse effect upon the Subsidiary. 
	 

	6.2 	Access to Information 

     To the extent the following items are in its possession or control, and until the sale of all of the Remaining Shares, the Parent shall afford Matco's officers, employees, counsel, investment bankers, accountants and other authorized representatives and advisors (the "Representatives") access at all reasonable times to the assets, books, contracts and records of the Subsidiary and of the Parent in respect of the Subsidiary, including, without limitation, the Books and Records, minute books and share registers of the Parent and the Subsidiary, and shall give Matco and its Representatives such copies and information with respect thereto as may be reasonably required and shall permit Matco to make such audit of the Books and Records and physical verification of the assets of the Parent and the Subsidiary as Matco may see fit. The Parent shall also provide Matco and its Representatives with access to the Parent's management personnel that have knowledge of the Subsidiary and any prior business operations. The Parent and the Subsidiary will also take such actions as are necessary to facilitate a debt or equity financing of the Subsidiary to occur after the Effective Time, including, as applicable, attendance by their respective directors and officers, as necessary, at due diligence sessions held by investment dealers or other advisors in respect of any such transaction. 

	6.3 	Notice of Misrepresentation or Breach 

     Each Party will promptly notify the other Parties if any representation made by it or, to the extent a Party has knowledge of the same, by another Party in this Agreement is or becomes untrue or incorrect or if a Party is aware that a breach of a covenant or warranty has or may have occurred prior to the expiry of the Guarantee Period. Such notice will set out particulars of the untrue or incorrect representation or breached covenant or warranty and details of any actions being taken to rectify that state of affairs, provided that if a Party is uncertain whether a misrepresentation or a breach of a covenant or warranty has occurred, then such Party shall promptly inform the other Parties of the full particulars of the occurrence giving rise to the uncertainty. 

ARTICLE 7 

REPRESENTATION AND WARRANTIES 

	7.1 	Parent Representations and Warranties 

     Unless a date is otherwise specified, the Parent represents and warrants to Matco as at the date of this Agreement and as at the Effective Time as follows, and acknowledges that Matco is and will be relying on such representations and warranties in connection with the performance of its obligations under this Agreement: 

	          (a)      	Corporate Standing of Parent: The Parent is duly incorporated, validly subsisting and in good standing under the laws of the Province of British Columbia and has all necessary corporate power, authority and capacity to enter into this Agreement and each and every agreement or document to be executed and delivered by it pursuant hereto and to perform its obligations hereunder and thereunder; 
	 

 

- 10 - 

	          (b)      	Corporate Standing of Subsidiary: The Subsidiary is duly incorporated, validly subsisting and in good standing under the laws of Canada, is registered to carry on business in British Columbia and is not registered to carry on business in any other jurisdiction; 
	 
	          (c)      	No Conflict: Except as set out in the Disclosure Schedule, the execution and delivery of this Agreement and each and every agreement or document to be executed and delivered pursuant hereto by the Parent or the Subsidiary and the consummation of the transactions contemplated hereby do not and will not 
	 
	 	(i)      	conflict with or constitute or result in a breach or default by the Parent or the Subsidiary of any provision of its constating documents, 
	 
	 	(ii)      	conflict with any agreement, instrument, permit or authority to which the Parent or the Subsidiary is a party or by which the Parent or the Subsidiary is bound, 
	 
	 	(iii)      	violate or conflict with any Applicable Laws applicable to the Parent or the Subsidiary, or 
	 
	 	(iv)      	give to any Person any interest or right that has not been waived prior to the date hereof, including a right to purchase any of the Subsidiary Shares, or any right of termination, cancellation or acceleration under any agreement, instrument, license, permit or authority to which the Parent or the Subsidiary is a party or by which the Parent or the Subsidiary is bound; 
	 
	          (d)      	Authorization and Execution: Each of the Parent and the Subsidiary has, to the extent applicable, taken all actions necessary to authorize the execution and delivery of this Agreement and each and every agreement or document to be executed and delivered pursuant hereto, this Agreement has been duly executed and delivered by the Parent and the Subsidiary, all documents to be executed and delivered hereunder by the Parent and the Subsidiary shall be duly executed and delivered, and this Agreement does and such documents will, when executed and delivered, constitute legal, valid and binding obligations of the Parent and the Subsidiary, as applicable, enforceable in accordance with their respective terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium and other similar laws of general application with respect to creditors and general principles of equity; 
	 
	          (e)      	Ownership of Subsidiary Shares: Except as set out in the Disclosure Schedule, the Parent is, has been since February 27, 2008, and will be until the Effective Time, the legal and beneficial owner of the Subsidiary Shares, and the Subsidiary Shares are and shall continue to be free and clear of all Encumbrances, there are no Acquisition Rights outstanding in respect of the Subsidiary other than hereunder in respect of the Convertible Debenture and there has been no Change of Control of the Subsidiary since January 1, 1999; 
	 
	          (f)      	Minute Books: Except as set out in the Disclosure Schedule, the minute books and corporate records of the Parent and the Subsidiary contain complete and accurate minutes of all meetings and proceedings of the shareholders and directors of the Parent and the Subsidiary, as applicable, since their respective dates of incorporation and the registers of transfers, shareholders and directors are complete and accurate in all material respects. 
	 
	 	Each of the Parent and the Subsidiary has kept and maintained such corporate records as are required under the laws of its jurisdiction of incorporation, and all such records are accurate, complete and up to date in all respects; 
	 

- 11 -

	 
	          (g)      	Shareholder Agreements: Except as set out in the Disclosure Schedule, there are no shareholders' agreements, voting trust agreements or other similar agreements relating to the Parent or the Subsidiary, the management of the Parent or the Subsidiary, or the shares or the ownership or voting of any of the issued and outstanding shares of the Parent or the Subsidiary; 
	 
	          (h)      	Issued Share Capital of Parent: The issued share capital of the Parent consists of 4,801,512 common shares, except as set out in the financial statements of the Parent or the notes thereto, or in the Disclosure Schedule there are no outstanding options, warrants, calls, convertible securities or other securities or rights to acquire securities of the Parent ("Acquisition Rights"), and to the knowledge of the Parent, except as set out in the Disclosure Schedule: 
	 
	 	(i)      	no Person, group of Persons, or Persons acting jointly or in concert owns, own, or has or have owned since the incorporation of the Parent, of record or beneficially, (i) more than 10% of the outstanding shares of the Parent or (ii) Acquisition Rights that if exercised would, when combined with shares of the Parent owned by such Person, Persons or group of Persons, result in such Person, Persons or group of Persons owning, of record or beneficially, more than 10% of the outstanding shares of the Parent; and 
	 
	 	(ii)      	no Person, group of Persons, or Persons acting jointly or in concert owns, own, or has or have owned since January 1, 1999, of record or beneficially, (i) more than 10% of the outstanding shares of the Subsidiary or (ii) Acquisition Rights that if exercised would, when combined with shares of the Subsidiary owned by such Person, Persons or group of Persons, result in such Person, Persons or group of Persons owning, of record or beneficially, more than 10% of the outstanding shares of the Subsidiary; 
	 
	          (i)      	Assets of Subsidiary: Immediately following the Reorganization, the Subsidiary will have no assets other than the Tax Attributes; 
	 
	          (j)      	Real Property of Subsidiary: Except as set out in the Disclosure Schedule, since January 1, 1992, the Subsidiary has not owned, either legally or beneficially, any real property and, to the knowledge of the Parent and the Subsidiary, the Subsidiary did not own, either legally or beneficially, any real property prior to January 1, 1999, except as set out in the Disclosure Schedule; 
	 
	          (k)      	Real Property Leases of Subsidiary: Except as set out in the Disclosure Schedule, the Subsidiary has not been a party to any real property lease since January 1, 1999 and, to the knowledge of the Parent and the Subsidiary, the Subsidiary was not a party to any real property lease prior to January 1, 1999, except as set out in the Disclosure Schedule; 
	 
	          (l)      	Agreements of Subsidiary: Other than agreements that will be assigned pursuant to the Reorganization, the Subsidiary is not a party to or otherwise bound by any agreement, contract or commitment, whether written or verbal, in respect of which the Subsidiary shall have any obligation or liability from and after the Effective Time; 
	 

- 12 - 

	          (m)      	Liabilities of Subsidiary: From and after the Effective Time, the Subsidiary will have no debts, liabilities or obligations, absolute or contingent, that have not been assumed at or prior to the Effective Time; 
	 
	          (n)      	Guarantees: The Subsidiary is not a party to or otherwise bound by any guarantee or agreement to grant a guarantee in respect of any debt, liability or other obligation of any Person in respect of which the Subsidiary shall have any liability from and after the Effective Time; 
	 
	          (o)      	No Options, etc.: No Person has any right, present or future, contingent or absolute (whether by law, pre-emptive or by contract), to purchase any of the Subsidiary Shares or to require the Subsidiary to issue any shares in its capital, there are no outstanding securities of the Subsidiary that are convertible into shares in the capital of the Subsidiary, and there are no outstanding options or rights to subscribe for any of the unissued shares in the capital of the Subsidiary; 
	 
	          (p)      	Authorized and Issued Capital of Subsidiary: The authorized capital of the Subsidiary at the date hereof consists of, and at the Effective Time will consist of, an unlimited number of common shares and an unlimited number of non-voting common shares, of which 38,412,100 common shares are issued and outstanding with 38,412,000 of such common shares being owned by the Parent and 100 of such common shares being owned by 1250280 Alberta Ltd. and all of such shares have been issued as fully paid and non- assessable shares; 
	 
	          (q)      	Transfer of Subsidiary Shares: 
	 
	 	(i)      	Except for the transfer of 100 Subsidiary Shares from the Parent to 10250280 Alberta Ltd. on March 18, 2008, there has been no transfer of any of the Subsidiary Shares since February 29, 2008; 
	 
	 	(ii)      	From the date hereof until the completion of a Corporate Opportunity, there will be no transfer of any of the Subsidiary Shares; 
	 
	          (r)      	Constating Documents of Subsidiary: The articles and bylaws of the Subsidiary are as set out in the minute book of the Subsidiary and have not been amended; 
	 
	          (s)      	Audited Financial Statements: All financial and other information provided or to be provided by the Parent and the Subsidiary to KPMG LLP to prepare the Audited Financial Statements is and will be correct and accurate and constituted and constitutes all of the information necessary in order to permit KPMG LLP to prepare the Audited Financial Statements in accordance with GAAP, and the Audited Financial Statements are, or will be in the case of the of Audited Financial Statements for the year ended December 31, 2007, complete and accurate in all material respects and present, or will present in the case of the of Audited Financial Statements for the year ended December 31, 2007, fairly the financial condition and position of the Subsidiary as at December 31, 2007, December 31, 2006, and December 31, 2005, and the results of its operations for the fiscal years ended on December 31, 2007, December 31, 2006, and December 31, 2005; 
	 
	          (t)      	Material Changes: Since December 31, 2007, other than as contemplated in this Agreement and except as set out in the Disclosure Schedule there has not been, in any material respect, 
	 

- 13 - 

	 	(i)      	any change in the accounting practices followed by the Subsidiary, other than as required by GAAP or as adopted for new transactions, 
	 
	 	(ii)      	any change in the constating documents of the Subsidiary, and the Subsidiary has not effected any subdivision, consolidation, reclassification or other modification of its share capital, 
	 
	 	(iii)      	any borrowing or increase in existing indebtedness or any liability incurred or any unusual acquisitions or purchases made by the Subsidiary, 
	 
	 	(iv)      	any cancellation of any debts or claims or waiver of any rights of value by the Subsidiary in connection with any aspect of its business whether or not in the ordinary course of its business, 
	 
	 	(v)      	any repayments of principal by the Subsidiary on any indebtedness owed by the Subsidiary to the Parent, 
	 
	 	(vi)      	any advances or loans by the Subsidiary to any Person, 
	 
	 	(vii)      	any declaration, setting aside or payment by the Subsidiary of any dividend or other distribution in respect of any shares in its capital, other than as part of the transfer of assets referred to in Section 3.2, 
	 
	 	(viii)      	any purchase or redemption by the Subsidiary of any shares in its capital, 
	 
	 	(ix)      	any bonus or other special payment made by the Subsidiary to the Parent or any of the Parent's employees, directors or officers; 
	 
	          (u)      	Taxes: 
	 
	 	(i)      	Tax Returns – All tax returns and reports of the Subsidiary required by law to be filed prior to the date hereof have been filed within the times and in the manner prescribed by Applicable Laws. All such tax returns and reports are true, complete and correct in all material respects and all Taxes shown to be payable on such tax returns have been paid or accrued in the Audited Financial Statements and the accounting and financial Books and Records of the Subsidiary; 
	 
	 	(ii)      	Tax – The Subsidiary has been assessed for federal and provincial income taxes for all years to and including the fiscal year ended December 31, 2006; 
	 
	 	(iii)      	Tax Status – Under the provisions of the Tax Act, the Subsidiary has at all times been and is now a taxable Canadian corporation; 
	 
	 	(iv)      	Provision for Taxes – Adequate provision has been made by the Subsidiary for Taxes payable for the current period for which tax returns are not yet required to be filed; 
	 
	 	(v)      	Extension Agreements – There are no agreements, waivers or other arrangements providing for an extension of time with respect to the filing of any tax return by or payment of any Taxes by the Subsidiary; 
	 

- 14 - 

	                    (vi)      	Collections and Withholdings – The Subsidiary has collected or withheld all amounts required to be collected or withheld by it on account of Taxes or otherwise and has remitted the same to the appropriate Governmental Entity in the manner and within the time required under any Applicable Laws or, if any such amount is not yet due, has set it aside in appropriate accounts for payment when due; 
	 
	                    (vii)      	Rulings – Except as set out in the Disclosure Schedule, the Subsidiary has not received any written ruling related to Taxes or entered into any agreement with a Governmental Entity relating to Taxes; 
	 
	                    (viii)      	Contingent Tax Liabilities – Except as set out in the Disclosure Schedule, the Parent is not aware of any contingent tax liabilities of the Subsidiary; 
	 
	                    (ix)      	Adverse Proceedings – There are no actions, suits, or other proceedings or proposals, investigations or claims in progress, pending or, to the knowledge of the Parent or the Subsidiary, threatened against the Subsidiary in respect of any Taxes of the Subsidiary or the Tax Attributes and there are no currently outstanding reassessments or written inquiries or proposals that have been issued or raised by any Governmental Entity relating to any Taxes or the Tax Attributes; 
	 

	          (v)      	Tax Residency of Subsidiary: The Subsidiary is not a non-resident of Canada within the meaning and for the purposes of the Tax Act; 
	 
	          (w)      	Fiscal Year End of Subsidiary: The fiscal year end of the Subsidiary is December 31; 
	 
	          (x)      	Books and Records of Subsidiary: The accounting and financial Books and Records of the Subsidiary set out and disclose all material financial transactions of the Subsidiary and such transactions have been accurately recorded in the Books and Record of the Subsidiary. The Books and Records of the Subsidiary are not wholly or partly recorded, stored or maintained or otherwise held by any means (including any electronic, mechanical or photographic process) not available to the Subsidiary in the ordinary course of its business; 
	 
	          (y)      	No Finders' Fees: Neither Matco nor the Subsidiary shall have any responsibility for any obligation or liability, contingent or otherwise, for brokers' or finders' fees, if any, incurred by the Parent or the Subsidiary with respect to the transactions contemplated hereby and, other than as set forth in the Disclosure Schedule, no such fees have been incurred; and 
	 
	          (z)      	Information Made Available to Matco: The Parent shall have made available to Matco all material information pertaining to or affecting the Parent and the Subsidiary and shall not have withheld from Matco any material documents or information reasonably required to not make misleading those documents and information made available by the Parent or the Subsidiary. 
	 

 

	7.2 	Matco Representations and Warranties 

     Matco hereby represents and warrants to the Parent as of the date of this Agreement as follows and acknowledges that the Parent is relying on such representations and warranties in connection with entering into this Agreement: 

- 15 - 

	          (a)      	Corporate Standing:  Matco is duly formed and validly subsisting under the laws of the Province of Alberta and has all necessary power, authority and capacity to enter into this Agreement and each and every agreement or document to be executed and delivered pursuant hereto by it and to perform its obligations hereunder and thereunder; 
	 
	          (b)      	No Conflict: The execution and delivery of this Agreement and each and every agreement or document to be executed and delivered pursuant hereto and the consummation of the transactions contemplated hereby does not and will not 
	 
	 	(i)      	conflict with or constitute or result in a breach or default by Matco of any provision of the constating documents of Matco, 
	 
	 	(ii)      	conflict with any agreement, instrument, permit or authority to which Matco is a party or by which Matco is bound, 
	 
	 	(iii)      	violate or conflict with any Applicable Laws applicable to Matco, or 
	 
	 	(iv)      	give to any Person any interest or right that has not been waived prior to the date hereof, including a right to purchase any of the Convertible Debenture or the Subsidiary Shares, or any right of termination, cancellation or acceleration under any agreement, instrument, license, permit or authority to which Matco is a party to or by which Matco is bound; 
	 
	          (c)      	Authorization and Execution: Matco has taken all actions necessary to authorize the execution and delivery of this Agreement and each and every agreement or document to be executed and delivered by it pursuant hereto and to perform its obligations hereunder and thereunder, this Agreement has been duly executed and delivered by Matco and all documents to be executed and delivered hereunder by Matco shall be duly executed and delivered, and this Agreement does and such documents will, when executed and delivered, constitute legal, valid and binding obligations of Matco, enforceable in accordance with their respective terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium and other similar laws of general application with respect to creditors, and general principles of equity; and 
	 
	          (d)      	No Finders' Fees: Neither the Parent nor the Subsidiary shall have any responsibility for any obligation or liability, contingent or otherwise, for brokers' or finders' fees, if any, incurred by Matco with respect to the transactions contemplated hereby. 
	 

  

- 16 - 

	7.3	No Merger and Survival

     There shall not be any merger of this Agreement or any representation or warranty contained herein with the agreements to be delivered pursuant hereto or any representation or warranty contained therein, notwithstanding any rule of law, equity or statute to the contrary, all or which rules are hereby waived. 

ARTICLE 8 

CONDITIONS PRECEDENT 

	8.1 	Conditions Precedent for the Benefit of Matco 

     The obligation of Matco to acquire the Convertible Debenture pursuant to Section 2.2 is conditional upon and subject to the satisfaction or fulfilment of each of following conditions on or prior to the Closing Date, unless an earlier date is specified: 

	          (a)      	the representations and warranties of the Parent contained in this Agreement shall be true and correct in all material respects as at the Effective Time with the same force and effect as if such representations and warranties were made at such time, and a certificate of the Parent, dated as of the Effective Time to that effect shall have been delivered by the Parent to Matco. Upon the delivery of such certificate, the representations and warranties of the Parent contained in this Agreement shall be deemed to have been made at the Effective Time with the same force and effect as if made at such time; 
	 
	          (b)      	all of the covenants, agreements and deliveries of the Parent to be performed by it pursuant to the terms of this Agreement at or before the Effective Time, including, without limitation, completion of the Reorganization on the terms contemplated herein, shall have been duly performed in all material respects; 
	 
	          (c)      	at or before April 4, 2008, Matco shall be satisfied with the results of its confirmatory due diligence investigations of the Parent and the Subsidiary with respect to (i) its review of the Audited Financial Statements and the other financial statements contemplated hereby, all tax returns and all actual or proposed filings or re-filings thereof, (ii) no outstanding Claims against the Parent or the Subsidiary, and (iii) the Reorganization and the valuation methodology and values utilized in connection therewith; 
	 
	          (d)      	no material adverse change having occurred or being reasonably expected to occur or no material fact in respect of the Parent or the Subsidiary that might reasonably be expected to result in a material adverse change in respect of the Subsidiary, 
	 
	          (e)      	no actual or threatened governmental or regulatory change that would have a material adverse effect on the value or utility of the Tax Attributes of the Subsidiary, and 
	 
	          (f)      	at or before the Effective Time there shall not have occurred a Change of Control of the Parent or the Subsidiary; 
	 
	          (g)      	the Subsidiary shall have made arrangements to grant a first ranking security interest in favour of Matco on the Closing Date, in a form and substance acceptable to Matco, acting reasonably, over all its personal property and such security interest shall have been registered wherever required to be opposable against third persons; 
	 

 

- 17 - 

	          (h)      	the receipt from all material creditors of the Parent or the Subsidiary and all parties to material contracts of the Parent or the Subsidiary, (as specified by Matco to the Parent on or before April 4, 2008) of required consents to the assumption of all liabilities by the Parent and releases of the Subsidiary from all liability to such parties, such acknowledgements to be in a form satisfactory to Matco, acting reasonably; 
	 
	          (i)      	all registrations or security interests against the Subsidiary shall have been discharged; and 
	 
	          (j)      	the obtaining by the Parent of satisfactory product liability insurance for ------- for the Subsidiary, at the Parent's cost or, alternatively, the Parent obtaining insurance for the benefit of the Subsidiary for any product liability claims for a period of -------, in each case to cover claims which may arise in connection with the business of the Subsidiary carried on prior to the Closing Date, and the Parent providing evidence to Matco that the Subsidiary will continue to have (after the Closing Date) the benefit of insurance maintained by the Parent before the Closing Date. 
	 

     The foregoing conditions are for the exclusive benefit of Matco and such conditions may be waived in whole or in part by Matco on or prior to the Closing Date by delivery to the Parent of a written waiver to that effect signed by Matco. 

	8.2 	Rights of Matco on Conditions 

     If any of the conditions for the exclusive benefit of Matco set forth in Section 8.1 shall not have been fulfilled or waived by Matco at or prior to the Closing Date, then Matco shall have no further obligation pursuant to this Agreement and may terminate this Agreement, and upon such termination the Parent shall return the Deposit to Matco and each Party shall be relieved of its obligations hereunder, provided that such termination shall not relieve any Party from its obligations pursuant to Article 10 and Section 11.2. 

	8.3 	Conditions Precedent
	 	 
	 	[Competitively sensitive information intentionally omitted.]

	 	 
	8.4	Conditions Precedent for the Benefit of the Parent

     Notwithstanding anything herein contained, the obligation of the Parent to continue to perform its obligations under this Agreement, including, without limitation, the obligation to cause the Subsidiary to issue the Convertible Debenture pursuant to Section 2.2, is conditional upon and subject to the satisfaction or fulfilment of each of the following conditions at or prior to the Effective Time: 

	Information regarding the manner in which the Parent and Matco will after the Closing Date source and pursue other opportunities to maximize the value of their respective interests in the Subsidiary and the proceeds to be received by the Parent as a result thereof has been redacted in the provision marked above on the basis of confidentiality.

 

-18 - 

	 	(a)      	the representations and warranties of Matco contained in this Agreement shall be true and correct in all material respects as at the Effective Time with the same force and effect as if such representations and warranties were made at such time, and a certificate of Matco dated as of the Effective Time to that effect shall have been delivered by Matco to the Parent at such time. Upon the delivery of such certificate, the representations and warranties of Matco contained in this Agreement shall be deemed to have been made at the Effective Time with the same force and effect as if made at such time; and 
	 	 	 
	 	(b)      	all of the covenants, agreements and deliveries of Matco to be performed by it pursuant to the terms of this Agreement at or before the Effective Time shall have been duly performed in all material respects and a certificate of Matco, dated as of the Effective Time to that effect shall have been delivered by Matco to the Parent at such time. 
	 	 	 

     The foregoing conditions are for the exclusive benefit of the Parent and such conditions may be waived in whole or in part by the Parent on or prior to the Effective Time by delivery to Matco of a written waiver to that effect signed by the Parent. 

	8.5 	Rights of the Parent on Conditions 

     If any of the conditions for the exclusive benefit of the Parent set forth in Section 8.4 shall not have been fulfilled or waived by the Parent at or prior to the Payment Date or if Matco breaches any term or condition of this Agreement, then the Parent may, by written notice to Matco, elect to 

	          (a)      	treat this Agreement as terminated by reason of the non-fulfilment or breach of Matco's obligations (other than each Party's obligations pursuant to Article 10 and Section 11.1) and, if the Parent so decides, pursue a claim for damages, or 
	 
	          (b)      	continue to treat this Agreement as binding and enforceable and to the extent necessary seek injunctive relief or an order for specific performance and, if the Parent so decides, pursue a claim for damages or specific performance in respect of this Agreement. 
	 

     The Parent shall be deemed to be treating this Agreement as binding and enforceable unless and until it specifically elects in writing to pursue the alternative in subparagraph (a) above.

ARTICLE 9 

  INDEMNITY 

	9.1      	Parent Indemnity of Matco 
	 
	 	The Parent shall 
	 
	 	(a)      	be liable and responsible for any and all Losses that Matco and its directors, officers, agents and employees may suffer, sustain, pay or incur; and 
	 
	 	(b)      	indemnify, release and save each of Matco and its directors, officers, agents and employees harmless from any and all Losses that may be brought against or suffered by Matco, its directors, officers, agents or employees or that any of them may suffer, sustain, pay or incur, 
	 

resulting from, arising out of, attributable to or connected with 

	          (c)      	any misrepresentation or breach of any covenant or warranty made by the Parent under this Agreement; or 
	 
	          (d)      	any failure by the Parent to observe or perform any covenant or agreement made by the Parent under this Agreement or any agreement executed and delivered pursuant hereto. 
	 

 

- 19 - 

  
   The indemnities described in subparagraphs (c) and (d) shall continue in full force and effect until the expiration of two years following the Effective Time, except for matters related to Taxes, which shall continue in full force and effect until the expiration of the applicable reassessment period in accordance with Applicable Laws.

	9.2      	Matco Indemnity of Parent 
	 
	 	Matco shall 
	 
	 	(a)      	be liable and responsible for any and all Losses that the Parent and its directors, officers, agents and employees may suffer, sustain, pay or incur and 
	 
	 	(b)      	indemnify, release and save each of the Parent and its directors, officers, servants, agents and employees harmless from and against any and all Losses that may be brought against or suffered by the Parent, its directors, officers, servants, agents or employees or that any of them they may suffer, sustain, pay or incur 
	 

resulting from, arising out of, attributable to or connected with 

	          (c)      	any misrepresentation or breach of any covenant or warranty made by Matco under this Agreement or 
	 
	          (d)      	any failure by Matco to observe or perform any covenant or agreement made by Matco under this Agreement or any agreement executed or delivered pursuant hereto. 
	 

     The indemnities described in paragraph (c) and (d) shall continue in full force and effect until the expiration of two years following the Effective Time. 

	9.3      	Parent Indemnity of the Subsidiary and Matco 
	 
	 	The Parent shall 
	 
	 	(a)      	be liable and responsible for any and all Losses that the Subsidiary, Matco or their respective directors, officers, agents and employees may suffer, sustain, pay or incur; and 
	 
	 	(b)      	indemnify, release and save the Subsidiary, Matco and each of their respective directors, officers, agents and employees harmless from any and all Losses that may be brought against or suffered by the Subsidiary, Matco or their respective directors, officers, agents or employees or that any of them may suffer, sustain, pay or incur 
	 

resulting from, arising out of, attributable to or connected with any Liabilities of the Subsidiary existing, incurred or arising at or prior to the Effective Time and all Losses that may be suffered by the Subsidiary at any time after the Effective Time that arise from or relate to any act, failure to act, matter or thing that occurred prior to the Effective Time. 

 

- 20 - 

ARTICLE 10

CONFIDENTIALITY 

	10.1 	Confidentiality 

     Except to the extent disclosure is required by Applicable Laws or is required in connection with a Corporate Opportunity, the Parties shall hold in confidence 

	          (a)      	any and all proprietary, confidential, trade secret and any other non-public information and data in relation to the business and affairs of a Party or this transaction, 
	 
	          (b)      	any and all proprietary, confidential, trade secret and any other non-public information and data in relation to a Party, and 
	 
	          (c)      	the terms and conditions of this Agreement and the fact that the Parties have entered into this Agreement, 
	 

and no Party shall disclose any of such information or use such information for its own purposes without the prior written consent of the other Parties, except to the Parties' professional advisors and the principals and professional advisors of any participant in a proposed Corporate Opportunity under a duty of confidentiality. The foregoing provisions set forth in this Section 10.1 shall not apply to (i) information that at the time of disclosure is or thereafter becomes generally available to and known by the public, (ii) information that is or was received on a non-confidential basis from a source other than a Party, or (iii) information that was known by a Party prior to disclosure hereunder and is not subject to a confidentiality obligation. 

ARTICLE 11 

  GENERAL 

	11.1 	Notices 

	          (a)      	Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be delivered in person, transmitted by facsimile or sent by courier addressed as follows: 
	 
	 	(i)      if to the Parent: 
	 

	                              Forbes Medi-Tech Inc. 
	                              Suite 200, 750 West Pender Street 
	                              Vancouver, B.C. V6C 2T8 
	                              Attention: 	         David Goold 
	                              Facsimile: 	         (604) 689-7641 

	                    (ii)      	if to Matco: 
	 
	 	Matco Capital Ltd.

        #400, 407 - 8th Avenue S.W.

        Calgary, Alberta T2P 1E5

        
	 
	 	Attention:   D. Alan Ross
	 
	 	Facsimile:    (403) 294-0105

 

- 21 -

	          (b)      	Any such notice or other communication shall be deemed to have been given and received on the day on which it was delivered or transmitted (or, if such day is not a Business Day, on the next following Business Day). 
	 
	          (c)      	Any Party may at any time change its address for service from time to time by giving notice to the other Parties in accordance with this Section 11.1. 
	 

	11.2 	Fees 

     Each of the Parties shall pay its own legal and accounting costs and other fees, costs and expenses of any nature or kind incurred in connection with the preparation, execution and delivery of this Agreement and all documents and instruments executed pursuant hereto, and the Parent or the Subsidiary shall pay the fees and expenses of PricewaterhouseCoopers LLP with respect to the transactions contemplated hereby and any other fees, costs or expenses incurred by KPMG LLP in connection with the preparation of the Audited Financial Statements (provided that the liability for all such fees and expenses shall be assumed by the Parent as part of the Reorganization). 

	11.3 	Further Assurances 

     Each Party covenants and agrees that it will at all times promptly execute and deliver all such documents, including, without limitation, all such additional conveyances, transfers, consents and other assurances, and do all such other acts and things as any other Party, acting reasonably, may from time to time request be executed or done in order to better evidence or perfect or effectuate any provision of this Agreement or of any agreement or other document executed pursuant to this Agreement or any of the respective obligations intended to be created hereby or thereby. 

	11.4 	Entire Agreement 

     This Agreement constitutes the entire agreement among the Parties with respect to the subject matter hereof and supersedes all prior agreements, understandings, negotiations and discussions, whether written or oral. There are no conditions, covenants, agreements, representations, warranties or other provisions, express or implied, collateral, statutory or otherwise, relating to the subject matter hereof other than as herein provided. 

	11.5 	Severability 

     If any provision of this Agreement is determined by a court of competent jurisdiction to be invalid, illegal or unenforceable in any respect, such determination shall not impair or affect the validity, legality or enforceability of the remaining provisions hereof, and each provision is hereby declared to be separate, severable and distinct. 

	11.6 	Amendments and Waivers 

     No amendment of any provision of this Agreement shall be binding on any Party unless it has been agreed to in writing by each of the Parties. No waiver of any provision of this Agreement shall constitute a waiver of any other provision, nor shall any waiver constitute a continuing waiver unless otherwise provided. 

	11.7 	Time of Essence 

Time shall be of the essence of this Agreement. 

- 22 - 

	11.8 	Successors and Assigns 

     This Agreement shall enure to the benefit of and shall be binding on the Parties and their respective successors and assigns and shall be enforceable by the Parties and their successors and permitted assigns. No Party may assign any of its rights or obligations hereunder without the prior written consent of the other Parties 

	11.9 	Applicable Laws 

     This Agreement shall be construed, interpreted and enforced in accordance with, and the respective rights and obligations of the Parties shall be governed by, the laws of the Province of Alberta and the federal laws of Canada applicable in the Province of Alberta without reference to conflicts of law principles, and each Party irrevocably and unconditionally submits to the non-exclusive jurisdiction of the courts of the Province of Alberta and all courts competent to hear appeals therefrom. 

	11.10 	Publicity 

     Each of the Parent, the Subsidiary and Matco shall advise, consult and cooperate with the other prior to issuing, or permitting any of its directors, officers, employees or agents to issue, any news release or other written public or private statement with respect to this Agreement, the transactions contemplated hereby or any other matters, from the date hereof until the Effective Time. Neither the Parent, the Subsidiary nor Matco shall issue any such news release or make any such written public or private statement prior to receiving the consent of the other Parties, such consent to not be unreasonably withheld, except as may be required by Applicable Law including, for greater certainty, in order to fulfill the Parent's continuous disclosure obligations under applicable securities laws or by obligations pursuant to any listing agreement with a stock exchange and only after using its commercially reasonable efforts to consult the other Parties. 

	11.11 	Counterparts and Facsimile Execution 

     This Agreement may be executed in counterparts and by facsimile, each of which counterparts shall constitute an original and all of which taken together shall constitute one and the same instrument. 

     IN WITNESS WHEREOF the Parties have made this Agreement effective as of the day and year first above written.

MATCO CAPITAL LTD.

Per: (signed)  "D. Alan Ross"  

FORBES MEDI-TECH INC. 

Per: (signed) "Charles Butt" 

FORBES MEDI-TECH OPERATIONS INC. 

Per: (signed) "Charles Butt" 

 

 

- 23 - 

SCHEDULE A 

SUMMARY OF TRANSACTION STEPS 

	1.      	Forbes Research & Manufacturing Inc. is to be wound up into the Subsidiary and all of the assets of Forbes Research & Manufacturing Inc. are to transferred to the Subsidiary and the Subsidiary is to assume all the liabilities of Forbes Research & Manufacturing Inc. 
	 
	2.      	The Transfer of the assets and liabilities of the Subsidiary is to take place as contemplated in Section 3.2 of the Agreement. 
	 
	3.      	The authorized capital of the Subsidiary is to be amended such that the Subsidiary shall be authorized to issue an unlimited number of non-voting shares. 
	 
	4.      	The stated capital of the Subsidiary Shares shall be reduced such that the stated capital of the Subsidiary Shares is no more than $100.00. 
	 
	5.      	The Subsidiary shall change its name as contemplated in Section 3.3 of the Agreement. 
	 

A-1 

SCHEDULE B 

DISCLOSURE SCHEDULE 

This disclosure schedule is made in connection with the representations and warranties set out in the Investment Agreement (the “Investment Agreement”) dated as of March 19, 2008 between Matco Capital Ltd., Forbes Medi-Tech Inc., and Forbes Medi-Tech Operations Inc.

This disclosure schedule is qualified in its entirety by reference to the Investment Agreement, and is not intended to constitute, and shall not be construed as constituting, representations and warranties of Forbes Medi-Tech Inc. or Forbes Medi-Tech Operations Inc. except as and to the extent provided in the Investment Agreement. Inclusion of information herein shall not be construed as an admission that such information is material to the business, operations or financial condition of any party or the transactions contemplated by the Investment Agreement. Any capitalized terms used but not otherwise defined herein shall have the meanings assigned to them in the Investment Agreement.

SECTION 7.1 – PARENT REPRESENTATIONS AND WARRANTIES 

Section 7.1(c): No Conflict 

   N/A 

Section 7.1(e): Ownership of Subsidiary Shares 

Any references to the Parent owning all of the Shares of the Subsidiary or in respect of any transfer of Subsidiary Shares are modified to reflect the purchase on March 18, 2008 by 1250280 Alberta Ltd. of one hundred common shares in the share capital of the Subsidiary. 

Section 7.1(f): Minute Books 

   N/A 

Section 7.1(g): Shareholder Agreements 

   N/A 

Section 7.1(h): Issued Share Capital of Parent 

As filed on April 10, 2006, Cantor Fitzgerald (consisting of Cantor Fitzgerald & Co.; Cantor Fitzgerald Securities; Cantor Fitzgerald L.P.; CF Group Management, Inc.; and Howard W. Lutnick) collectively owned 4,514,396 common shares of the Subsidiary, accounting for 13.2% of the total number of voting securities, for investment purposes. As filed on June 18, 2006, Cantor Fitzgerald held a reported 15% interest (5,771,144 shares as per SEDI filings) in the Subsidiary. 

As filed, Cantor Fitzgerald began disposing of its holdings in the Subsidiary on December 4, 2006. As filed on January 11, 2007, Cantor Fitzgerald collectively owned 0 common shares of the Subsidiary, accounting for 0% of the total number of voting securities. 

 

B-1 

Section 7.1(j): Real Property of Subsidiary 

Real Property Owned by Forbes Research & Manufacturing Inc. prior to winding-up: 

An immovable and real property located at 310 rue des Forges, Amqui, Quebec (the “Property”) and equipment located thereon purchased from Bayer Inc., on November 9, 1998. 

The Property was sold August 9, 2002 to 3824527 Canada Inc. (o/a Chaichem Pharmaceuticals). 

Section 7.1(k): Real Property Leases of Subsidiary 

Office Leases 

	          1.      	Sublease with Landlord’s Consent dated September 9, 1999 between C.M. Oliver & Company Limited (Tenant) and Forbes Medi-Tech Inc. (Subtenant) and Pacific Centre Leaseholds Limited (Landlord) 
	 
	          2.      	Office Lease dated December 2, 2002 between Pacific Centre Leaseholds Limited (Landlord) and Forbes Medi-Tech Inc. (Tenant) 
	 
	          3.      	Lease Amending Agreement dated December 1, 2003 between Pacific Centre Leaseholds Limited (Landlord) and Forbes Medi-Tech Inc. (Tenant) 
	 
	          4.      	Lease Amendment and Expansion Proposal (Suite 200 & 210, 750 West Pender Street, Vancouver, BC) dated February 28, 2005 between Pacific Centre Leaseholds Limited (Landlord) and Forbes Medi-Tech Inc. (Tenant) 
	 
	          5.      	Lease Amending and Extension Agreement dated March 24, 2005 between Pacific Centre Leaseholds Limited (Landlord) and Forbes Medi-Tech Inc. (Tenant) 
	 
	          6.      	Sublease Agreement dated December 5, 2007 between Pacific Centre Leaseholds Limited (Landlord) and Forbes Medi-Tech Inc. (Tenant) and TTM Resources Inc. (Sub-Tenant) 
	 
	          7.      	Residential Tenancy Agreement dated December 1, 2004, effective as of December 1, 2003, between Forbes Medi-Tech Inc. and Vancouver Rental Properties Ltd. for the apartment located at 2005 – 1288 Alberni Street (President’s apartment – month to month lease for $2,500/month) 
	 

Laboratory Leases 

	          1.      	Sublease dated May 15, 2000 between Forbes Medi-Tech Inc. (Tenant) and Discovery Parks Incorporated (Landlord) – for the premises located at UBC, 402 – 2389 Health Sciences Mall, Vancouver, BC, V6T 1Z3 
	 
	          2.      	Sub-Sublease dated July 15, 2003 between Forbes Medi-Tech Inc. (Sublandlord) and Cavendish Analytical Laboratory Ltd. (Subtenant) – for the premises located at UBC, 402 – 2389 Health Sciences Mall, Vancouver, BC, V6T 1Z3 
	 
	          3.      	Office Lease Agreement commencing May 1, 2003 between the University of British Columbia (Landlord) and Forbes Medi-Tech Inc. (Tenant) – for the premises located at UBC, Food Science Building, 6650 N.W. Marine Drive, Vancouver, BC, V6T 1Z4 [this building was torn down and Tenant was moved to the Food, Nutrition and Health Building, Faculty of Land and Food Systems, 2205 East Mall, UBC, Vancouver, BC, Canada V6T 1Z4 – no new lease was signed]. This lease was terminated on December 31, 2007. 
	 

B-2 

 To the knowledge of the Parent and the Subsidiary, the Subsidiary was a party to the following real property leases prior to 1999: 

Office Leases 

1. 1995 to November 1997, 1500 – 701 West Georgia Street, Vancouver, BC 

2. November 1997 to November 1999, 2000 – 1066 West Hastings Street, Vancouver, BC 

Laboratory Leases 

1. 1999 to 2000 JR Laboratories Inc., #12 – 3871 North Fraser Way, Burnaby, BC, V5J 5G6 

Section 7.1(t): Material Changes 

The stated capital of the Subsidiary’s common shares was reduced by $98,460,000 following a special resolution of the Subsidiary’s shareholders passed on February 14, 2008. 

Some bonuses (approximately $200,000) for the year ended December 31, 2007 will be paid to the officers and employees of the Subsidiary (the employees of the Parent following the transfer of assets and liabilities of the Subsidiary to the Parent contemplated in Section 3.2 of the Investment Agreement). The final individual amounts and timing of payments have not yet been finalized (the liability for any such payments will be assumed by the Parent as contemplated in Section 3.2 of the Investment Agreement). 

Section 7.1(u): Taxes 

Section 7.1(u)(vii): Rulings 

N/A 

Section 7.1(u)(viii): Contingent Tax Liabilities 

N/A 

Section 7.1(y): No Finders’ Fees 

Fees will be paid pursuant to the engagement letter between Forbes Medi-Tech Inc. and PricewaterhouseCoopers LLP Corporate Finance dated June 5, 2007 for financial advisory services. 

This agreement will be assumed by the Parent prior to the Closing Date, and the Subsidiary will be released from its obligations thereunder. 

B-3

SCHEDULE C 

FORM OF CONVERTIBLE DEMAND DEBENTURE 

Principal Amount: $3,000,000 (Cdn.) 

  Holder: Matco Capital Ltd.

8% CONVERTIBLE DEMAND DEBENTURE 

     Forbes Medi-Tech Operations Inc. (hereinafter referred to as the "Corporation"), a corporation duly incorporated and existing under the laws of Canada, for value received, hereby acknowledges itself indebted and promises to pay on demand or April 30, 2009, whichever is earlier (such date being referred to herein as the "Due Date"), to or to the order of Matco Capital Ltd.(hereinafter referred to as the "Holder") the Principal Amount, as set out above, subject to adjustment in accordance with the Investment Agreement dated March 19, 2008 among the Corporation, the Holder and Forbes Medi-Tech Inc. in lawful money of Canada upon presentation and surrender of this Debenture at the principal offices of the Corporation or at such other place in Canada as the Holder may designate in writing, and to pay interest on the Principal Amount from the date hereof at the rate of 8% per annum, calculated and compounded semi-annually, both before and after the Effective Date of Conversion (as defined herein) until such interest and principal amount is paid in full and, should the Corporation at any time default in payment of any principal or interest, to pay, on demand, interest both before and after default and judgment on the amount in default at the same rate in like money. The interest rate specified herein is intended to be a nominal rate and not an effective rate of interest. 

RIGHT OF CONVERSION 

	1.	(a)    	Conversion at the Demand of Holder: Upon and subject to the provisions and conditions herein contained, the Holder shall have the right, at any time, upon the giving of written notice to the Corporation (the "Conversion Notice"), to convert all or, in the sole discretion of the Holder, any part of the outstanding Principal Amount of this Debenture into • common shares of the Corporation (the "Common Shares") and • non-voting shares of the Corporation (the "Non-Voting Shares") (the Common Shares and Non-Voting Shares are collectively referred to herein as the "Shares"), as adjusted pursuant to Section 15 hereof, at a conversion price of $• per Common Share and $• per Non-Voting Share, as adjusted from time to time, (the "Conversion Ratio") such that, for greater clarity and subject to adjustment, $• of the Principal Amount of this Debenture shall be convertible into the Common Shares and $• of the Principal Amount of this Debenture shall be convertible into the Non-Voting Shares and in the event the Holder at any time converts less than all of the Principal Amount of this Debenture then the Holder shall elect, in the sole discretion of the Holder with such election to be made in the Conversion Notice provided by the Holder in connection with such conversion, the portion of the Principal Amount of this Debenture to be converted into Common Shares, if any, and the portion of the Principal Amount of this Debenture to be converted into Non-Voting Shares, if any, and such election shall be binding on the Corporation. 

	 	 	Procedure for conversion: If the Holder desires to convert this Debenture into Shares in whole or in part, the Holder shall deliver a written notice (signed by the Holder or his

      attorney or agent) to the Corporation exercising its right to convert this Debenture, together with this Debenture. Upon the delivery of the said notice, the Holder or such 
	 	(b) 
	 	 

 

C-1 

	 	other person in whose name the Shares are to be issued, as designated in the said notice, shall be deemed, for all purposes, to be the holder of record of such number of fully paid and non-assessable Shares into which this Debenture may be converted on the basis contemplated in Subsection 1(a) and such person or persons shall be entitled to delivery by the Corporation of a certificate or certificates representing such Shares promptly after the exercise of such right of conversion. The Corporation shall thereupon cancel this Debenture to reflect the payment in full of the Principal Amount if the conversion is of the entire Principal Amount hereof or shall endorse this Debenture to reflect a partial payment if the conversion relates to part of the Principal Amount. 
	 
	          (c)      	Approvals and Registrations: The Corporation will take such action as may be necessary to secure all registrations and approvals as may be required by applicable statutes or regulations for the issuance of the Shares upon conversion of this Debenture in whole or in part. 
	 
	          (d)      	Adjustment for interest or dividends: If this Debenture is converted pursuant to Subsection 1(a), then, notwithstanding anything herein to the contrary, the Corporation will pay to the Holder interest accrued hereunder up to the date upon which the Holder is deemed to be the holder of record of the Shares issuable upon conversion as provided in Subsection 1(a) (the "Effective Date of Conversion"), such interest to be paid on the Effective Date of Conversion. 
	 
	          (e)      	Reservation of Shares: So long as this Debenture is outstanding, the Corporation shall reserve and conditionally allot against the conversion rights conferred to the Holder by this Debenture a sufficient number of Shares to enable this Debenture to be converted upon the basis provided for in Subsection 1(a). All Shares issued upon exercise of the right of conversion herein provided for shall be issued as fully paid and non-assessable Shares. 
	 

EVENTS OF DEFAULT 

	2.      	Events of Default: Notwithstanding the fact that the Principal Amount is payable on demand, the happening of any one or more of the following events shall be considered an event of default (each an "Event of Default"): 
	 
	 	(a)      	if the Debtor makes default in payment of the Principal Amount of the Debenture when the same becomes due and payable under any provision hereof; 
	 
	 	(b)      	the Debtor does not observe or perform any of the Debtor’s obligations under this Agreement or any other agreement or document existing at any time between the Debtor and the Holder; 
	 
	 	(c)      	any representation, warranty or statement made by or on behalf of the Debtor to the Holder is untrue in any material respect at the time when or as of which it was made; 
	 
	 	(d)      	the Debtor: (i) makes a proposal or files an assignment for the benefit of creditors under the Bankruptcy and Insolvency Act (Canada) or similar legislation in Canada or any other jurisdiction; (ii) a petition in bankruptcy is filed against the Debtor; (iii) steps are taken under any legislation by or against the Debtor seeking its liquidation, winding-up, dissolution or reorganization or any arrangement or composition of its debts; or (iv) proceedings are instituted to petition the Debtor into bankruptcy under the Bankruptcy and Insolvency Act (Canada) or similar legislation in Canada or any other jurisdiction which remain undischarged on the 60th day after they are instituted; 
	 

C-2 

	 
	          (e)      	a Receiver, trustee, custodian or other similar official is appointed in respect of the Debtor or any of the Debtor’s property; 
	 
	          (f)      	the holder of a charge, other than the Holder, takes possession of all or any part of the Debtor’s property, or a distress, execution or other similar process is levied against all or any part of such property; 
	 
	          (g)      	if an event of default, as defined in any indenture or instrument under which the Debtor has at the time hereof or shall hereafter have outstanding in respect of any indebtedness for borrowed money, shall have occurred and be continuing and such indebtedness shall have been accelerated; 
	 
	          (h)      	if the Debtor shall neglect to observe or perform any other covenant or condition herein contained on its part to be observed or performed and after notice in writing has been given by the Holder to the Debtor specifying such default and requiring the Debtor to rectify the same, the Debtor shall fail to make good such default within a period of 15 days unless the Holder (having regard to the subject matter of the default) shall have agreed to a longer period and in such event within the period agreed to by the Holder; or 
	 
	          (i)      	if an encumbrancor shall lawfully take possession of the property of the Debtor or any part thereof which is a substantial part thereof or if a distress or execution or any similar process shall be levied or enforced against and remains unsatisfied for or is not discharged within 30 days. 
	 

ENFORCEMENT 

	3.      	Enforcement of Security: Upon the occurrence and during the continuance of any Event of Default, the Holder will be entitled to demand payment of any amount due hereunder and to enforce its rights under any security granted in its favour. 
	 

COVENANTS AND REPRESENTATIONS OF THE CORPORATION 

	4.      	Certain Covenants by the Corporation: The Corporation hereby covenants and agrees: 
	 
	 	(a)      	To Pay Principal and Interest: That the Corporation will duly and punctually pay or cause to be paid to the Holder the principal of and interest accrued on this Debenture and other amounts payable hereunder on the dates, at the places, in the moneys, and in the manner mentioned herein. 
	 
	 	(b)      	To Carry on Business: Any business carried on by the Corporation will be conducted in a proper and efficient manner; and at all reasonable times it will furnish or cause to be furnished to the Holder or its duly authorized agent or attorney such information relating to the business of the Corporation as the Holder may reasonably require; and, subject to the express provisions hereof, it will do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence and rights. 
	 

	4.B    	Certain Representations and Warranties by the Corporation: The Corporation represents and warrants: 

C-3 

	          (a)      	Incorporation, Licenses and Qualification: That the Corporation is a body corporate, duly incorporated, properly organized and validly existing under the laws of its jurisdiction of incorporation and is duly registered and qualified to do business under the laws of each other jurisdiction in which the character of the properties owned by it or the nature of the activities conducted by it made such registration or qualification advisable or necessary and that it will maintain such status. 
	 
	          (b)      	Power, Authority, Execution and Delivery: That the Corporation has full power and lawful authority to enter into this Debenture, to create and grant this Debenture, and has duly executed and delivered this Debenture and that the that the Corporation has full power and lawful authority to enter into the general security agreement between the Holder and the Corporation dated April •, 2008 (the "GSA"), and the security contemplated thereby and has duly executed and delivered the GSA. 
	 
	          (c)      	Enforceability: That each of this Debenture and the GSA constitutes a valid and legally binding obligation of the Corporation enforceable against the Corporation in accordance with its terms, subject only to bankruptcy, insolvency or other statutes or judicial decisions affecting the enforcement of creditor's rights generally and to general principles of equity. 
	 
	          (d)      	Non-Conflict: Neither the execution nor the performance of this Debenture nor the GSA requires the approval of any regulatory agency having jurisdiction over the Corporation which has not been obtained, nor is this Debenture or the GSA in contravention of or in conflict with the articles, by-laws or resolutions of the directors or shareholders of the Corporation or any unanimous shareholders agreement relating to the Corporation or of the provisions of any agreement to which the Corporation is a party or by which any of its property may be bound or of any statute, regulation, by-law, ordinance or other law, or of any judgment, decree, award, ruling or order to which the Corporation or any of its property may be subject. 
	 
	          (e)      	No Default: The Corporation is not in material breach of any material agreement to which it is a party or its assets are bound. 
	 

MISCELLANEOUS 

	5.      	Limitation on Voting: Notwithstanding any other provision herein, in no event shall this Debenture be convertible into a number of shares of the Corporation such that the Holder would own or control directly or indirectly in any manner whatsoever in excess of 35% of the voting shares of the Corporation issued and outstanding on the Effective Date of Conversion. 
	 
	6.      	Replacement of Debenture Mutilated, Lost or Destroyed: If this Debenture is mutilated lost or destroyed, the Corporation shall issue and deliver to the Holder, a new Debenture of like tenor as the one mutilated, lost or destroyed, in exchange for and in place of and upon cancellation of such mutilated Debenture, or in lieu of and in substitution for such lost or destroyed Debenture, provided, however, that the Corporation shall have first received an indemnity in form and as to execution satisfactory to it in its reasonable discretion. 
	 
	7.      	Notices: All notices given hereunder to the Holder or to the Corporation shall be in writing and personally delivered during normal business hours or sent by prepaid registered mail if to the Holder at #400, 407 - 8th Avenue S.W., Calgary, Alberta T2P 1E5 unless otherwise instructed, or if to the Corporation at Suite 200, 750 West Pender Street, Vancouver, B.C. V6P 2T8 or such 
	 

 

C-4 

	 	addresses as it may give notice of to the Holder. Every such notice shall be deemed to have been given on the third business day following the day when it is posted or on the day when it is delivered. 
	 
	8.      	Application of Moneys: Except as herein otherwise expressly provided, any moneys paid on account of this Debenture, whether paid by the Corporation or as a result of legal or other proceedings or from any trustee in bankruptcy or liquidator of the Corporation shall be applied as follows: 
	 
	 	(a)      	first, in payment or in reimbursement to the Holder of its costs, charges and expenses as required by Section 9 with interest thereon as herein provided; 
	 
	 	(b)      	second, in payment to the Holder, of accrued and unpaid interest and interest on amounts in default on the Debenture which shall then be outstanding; and 
	 
	 	(c)      	third, in payment to the Holder of the outstanding Principal Amount of the Debenture. 
	 
	9.      	Expenses: The Corporation agrees to pay to the Holder forthwith on demand all costs, charges and expenses, including all legal fees (on a solicitor and his own client basis), incurred by the Holder in connection with the recovery or enforcement of payment of the Principal Amount of and interest on this Debenture and any other moneys payable hereunder whether by realization or otherwise. All such sums shall bear interest at the rate set forth above. 
	 
	10.      	Exclusion of Liability of Holder: The Holder shall not be liable for any failure to exercise its rights, powers or remedies arising hereunder or otherwise. 
	 
	11.      	Effect of Headings: The headings of all the preceding sections, subsections and paragraphs are inserted for convenience of reference only and shall not affect the construction or interpretation of this Debenture. References herein to sections and subsections are references to sections or subsections of this Debenture unless otherwise specified or otherwise required by the context. 
	 
	12.      	Formal Date: This debenture may be referred to as bearing the formal date of •, 2008, notwithstanding its actual date of execution. 
	 
	13.      	Assignment: this Debenture may be assigned by the Holder or its successors and assigns at any time and from time to time. The Corporation shall not assign this Debenture. 
	 
	14.      	Governing Law: The Debenture shall be construed in accordance with the laws of the Province of Alberta and the federal laws of Canada applicable therein excluding reference to conflicts of laws principles, and shall be treated in all respects as a contract entered into in the Province of Alberta. 
	 
	15.      	[Business sensitive information intentionally omitted.]
	 

	Information regarding pricing has been redacted in the provision marked above on the basis of confidentiality.

 

C-5 

     IN WITNESS WHEREOF the Corporation has duly executed this Debenture as of the ____ day of _______________, 2008. 

FORBES MEDI-TECH OPERATIONS INC. 

Per: __________________________________

C-6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00156-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00156-of-00352.parquet"}]]